针对鼻癌的新型治疗开发
Jongwoo Kim1, Yunjoo Lee2,3,4, Seoin Kim1
1MetroWest Medical Center, Framingham, MA 01702, USA.
Current oncology (Toronto, Ont.)
|September 26, 2025
概括
鼻癌 (NPC) 治疗正在发展. 新的策略结合了免疫疗法,向药物和生物标志物,以克服耐药性并改善复发性或转移性疾病的结果.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 鼻癌 (NPC) 是一种罕见的癌症,与爱斯坦-巴尔病毒 (EBV) 密切相关.
- EBV蛋白质是NPC瘤发生的关键驱动因素,影响免疫逃避,细胞死亡和瘤生长.
- 复发性和转移性 (R/M) NPC 的治疗耐药性需要新的治疗策略.
研究的目的:
- 审查R/M NPC当前和新兴的治疗策略.
- 突出EBV在NPC病原和治疗开发中的作用.
- 讨论免疫疗法,向药物和生物标志物的整合.
主要方法:
- 对NPC疗法的当前研究进行文献综述.
- 分析EBV在NPC发展和治疗反应中的作用.
- 探索新兴的免疫治疗和向治疗方式.
主要成果:
- 免疫检查点抑制剂 (ICI) 是有前途的,但却面临抗药性.
- 特定于EBV的采用细胞疗法和疫苗旨在提供持久的抗病毒免疫力.
- 像TKI和ADC这样的向疗法提供了精准医学方法.
结论:
- 综合免疫疗法和向药物的多模式,生物驱动的方法对于R/M NPC至关重要.
- 生物标志物驱动的策略将优化治疗选择和患者的结果.
- 利用EBV在NPC中的作用提供了独特的治疗机会.
更多相关视频
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
2.2K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.6K
相关概念视频
01:30Cancer Vaccines
972
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
972
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
588
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
588